首页 > 最新文献

M S-medecine Sciences最新文献

英文 中文
[Systemic ASBT inhibition as a therapeutic target for cholestasis]. [全身 ASBT 抑制作为胆汁淤积症的治疗靶点]。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 Epub Date: 2024-12-10 DOI: 10.1051/medsci/2024157
Alexandra Boitard, Mélanie Gonçalves, Tala Hajar, Thomas Falguières
{"title":"[Systemic ASBT inhibition as a therapeutic target for cholestasis].","authors":"Alexandra Boitard, Mélanie Gonçalves, Tala Hajar, Thomas Falguières","doi":"10.1051/medsci/2024157","DOIUrl":"https://doi.org/10.1051/medsci/2024157","url":null,"abstract":"","PeriodicalId":18205,"journal":{"name":"M S-medecine Sciences","volume":"40 11","pages":"879-881"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Basophil granulocytes control pathogenic accumulation of T follicular helper cells during lupus]. [嗜碱性粒细胞控制狼疮期间T滤泡辅助细胞的致病性积累]。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 Epub Date: 2024-12-10 DOI: 10.1051/medsci/2024143
Quentin Simon, John Tchen, Nicolas Charles
{"title":"[Basophil granulocytes control pathogenic accumulation of T follicular helper cells during lupus].","authors":"Quentin Simon, John Tchen, Nicolas Charles","doi":"10.1051/medsci/2024143","DOIUrl":"https://doi.org/10.1051/medsci/2024143","url":null,"abstract":"","PeriodicalId":18205,"journal":{"name":"M S-medecine Sciences","volume":"40 11","pages":"815-818"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Force-Velocity-Endurance (FoVE) Model: a new method for functional striated skeletal muscle in situ evaluation in murine models]. [力-速度-耐力(FoVE)模型:在小鼠模型中原位评估横纹骨骼肌功能的新方法]。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 Epub Date: 2024-11-18 DOI: 10.1051/medsci/2024137
Maximilien Bowen, Christophe Hourdé, Anne-Cécile Durieux, Damien Freyssenet, Pierre Samozino, Baptiste Morel

The FoVE model is a new theoretical framework coupled with innovative modeling to evaluate the striated skeletal muscle function. The theoretical model is based on two fundamental relationships: the force-velocity relationship and the force-time relationship. These relationships describe the muscle force production capacity as a function of contraction velocity and exercise duration, respectively. By combining them, the FoVE model offers a comprehensive view of the muscle functional capacities at various velocities, with and without fatigue. A unique experimental protocol has been developed using an isokinetic force measurement system to obtain the FoVE parameters of the model. This protocol enables muscle force to be measured at various contraction velocities for a total duration of 3 minutes. Applied to mouse model, the results obtained with the FoVE model show significant differences in the functional capacity of the tibialis anterior muscle. Females have a higher normalized initial maximal force. Conversely, males have a higher initial maximum velocity capacity under fatigue conditions. This approach provides a comprehensive mapping of muscle function, surpassing traditional assessments of isometric strength. It can be applied to basic research in pre-clinical models and translational research in humans.

FoVE 模型是一个新的理论框架,结合创新的建模方法来评估横纹骨骼肌的功能。该理论模型基于两个基本关系:力-速度关系和力-时间关系。这两种关系分别描述了肌肉产力能力与收缩速度和运动持续时间的函数关系。通过将它们结合起来,FoVE 模型提供了在不同速度、有疲劳和无疲劳情况下肌肉功能能力的综合视图。为了获得该模型的 FoVE 参数,我们使用等速肌力测量系统开发了一种独特的实验方案。通过该实验方案,可在各种收缩速度下测量肌肉力量,总持续时间为 3 分钟。将 FoVE 模型应用于小鼠模型,结果显示胫骨前肌的功能能力存在显著差异。雌性的归一化初始最大力量更高。相反,雄性在疲劳条件下的初始最大速度能力较高。这种方法提供了全面的肌肉功能图谱,超越了传统的等长力量评估。它可应用于临床前模型的基础研究和人类的转化研究。
{"title":"[Force-Velocity-Endurance (FoVE) Model: a new method for functional striated skeletal muscle in situ evaluation in murine models].","authors":"Maximilien Bowen, Christophe Hourdé, Anne-Cécile Durieux, Damien Freyssenet, Pierre Samozino, Baptiste Morel","doi":"10.1051/medsci/2024137","DOIUrl":"https://doi.org/10.1051/medsci/2024137","url":null,"abstract":"<p><p>The FoVE model is a new theoretical framework coupled with innovative modeling to evaluate the striated skeletal muscle function. The theoretical model is based on two fundamental relationships: the force-velocity relationship and the force-time relationship. These relationships describe the muscle force production capacity as a function of contraction velocity and exercise duration, respectively. By combining them, the FoVE model offers a comprehensive view of the muscle functional capacities at various velocities, with and without fatigue. A unique experimental protocol has been developed using an isokinetic force measurement system to obtain the FoVE parameters of the model. This protocol enables muscle force to be measured at various contraction velocities for a total duration of 3 minutes. Applied to mouse model, the results obtained with the FoVE model show significant differences in the functional capacity of the tibialis anterior muscle. Females have a higher normalized initial maximal force. Conversely, males have a higher initial maximum velocity capacity under fatigue conditions. This approach provides a comprehensive mapping of muscle function, surpassing traditional assessments of isometric strength. It can be applied to basic research in pre-clinical models and translational research in humans.</p>","PeriodicalId":18205,"journal":{"name":"M S-medecine Sciences","volume":"40 Hors série n° 1 ","pages":"69-73"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[New Split-GFP systems to follow organelle contact sites in yeast and human cells]. [用于跟踪酵母和人类细胞中细胞器接触点的新型 Split-GFP 系统]。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 Epub Date: 2024-12-10 DOI: 10.1051/medsci/2024155
Carine Amseyan, Amy Blondeau, Julien Karazi, Marie Erard
{"title":"[New Split-GFP systems to follow organelle contact sites in yeast and human cells].","authors":"Carine Amseyan, Amy Blondeau, Julien Karazi, Marie Erard","doi":"10.1051/medsci/2024155","DOIUrl":"https://doi.org/10.1051/medsci/2024155","url":null,"abstract":"","PeriodicalId":18205,"journal":{"name":"M S-medecine Sciences","volume":"40 11","pages":"873-875"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[From incomplete penetrance to variable expressivity or vice versa]. [从不透明性到可变表达性或反之亦然]。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 Epub Date: 2024-12-10 DOI: 10.1051/medsci/2024148
Hélène Gilgenkrantz
{"title":"[From incomplete penetrance to variable expressivity or vice versa].","authors":"Hélène Gilgenkrantz","doi":"10.1051/medsci/2024148","DOIUrl":"https://doi.org/10.1051/medsci/2024148","url":null,"abstract":"","PeriodicalId":18205,"journal":{"name":"M S-medecine Sciences","volume":"40 11","pages":"864-865"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[DUSP6, a potential target to prevent leukemic progression in myeloproliferative neoplasms]. [DUSP6--骨髓增生性肿瘤中预防白血病进展的潜在靶点]。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 Epub Date: 2024-12-10 DOI: 10.1051/medsci/2024156
Quentin Provôt, Nathan Fiévet, Yasmine Liza Mechouek, Iléana Antony-Debré, Brahim Arkoun
{"title":"[DUSP6, a potential target to prevent leukemic progression in myeloproliferative neoplasms].","authors":"Quentin Provôt, Nathan Fiévet, Yasmine Liza Mechouek, Iléana Antony-Debré, Brahim Arkoun","doi":"10.1051/medsci/2024156","DOIUrl":"https://doi.org/10.1051/medsci/2024156","url":null,"abstract":"","PeriodicalId":18205,"journal":{"name":"M S-medecine Sciences","volume":"40 11","pages":"876-878"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The new generations of CAR-T cells]. [新一代 CAR-T 细胞]。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 Epub Date: 2024-12-10 DOI: 10.1051/medsci/2024151
Djamel Messaoudi, Franck Perez, Zélia Gouveia

Chimeric antigen receptor (CAR)-T is one of the most promising modern cancer immunotherapies. In the recent years, impressive results have been obtained in the treatment of cancer which led to FDA approval for the treatment of liquid tumors. In this cell-based therapy, immune cells (e.g. T and NK cells) are engineered to express a synthetic receptor CAR to specifically recognize and eliminate cells expressing a target antigen. CAR has evolved through different generations aiming to boost its biological activity and overcome limitations such as low persistence, limited potency, life-threatening toxicity and inefficient activity against solid tumor. The present review provides an overview of the different CAR generations, starting from the 1st generation with limited cytotoxic activity until the latest generation, the 5th generation or new generation, developed to overcome various limitations of CAR T therapy. The current ongoing clinical trials in cancer and autoimmune diseases, and the limitation associated with CAR-T cells in cancer therapy, are also discussed.

嵌合抗原受体(CAR)-T 是最有前途的现代癌症免疫疗法之一。近年来,该疗法在癌症治疗方面取得了令人瞩目的成果,并被美国食品及药物管理局批准用于液态肿瘤的治疗。在这种以细胞为基础的疗法中,免疫细胞(如 T 细胞和 NK 细胞)被设计为表达合成受体 CAR,以特异性识别和清除表达靶抗原的细胞。CAR 经过了不同世代的发展,旨在提高其生物活性,克服持久性低、效力有限、毒性危及生命以及对实体瘤活性低等局限性。本综述概述了不同世代的 CAR,从细胞毒性活性有限的第一代开始,直到最新的第五代或新一代,它们都是为了克服 CAR T 疗法的各种局限性而开发的。本文还讨论了目前正在进行的癌症和自身免疫性疾病临床试验,以及 CAR-T 细胞在癌症治疗中的局限性。
{"title":"[The new generations of CAR-T cells].","authors":"Djamel Messaoudi, Franck Perez, Zélia Gouveia","doi":"10.1051/medsci/2024151","DOIUrl":"https://doi.org/10.1051/medsci/2024151","url":null,"abstract":"<p><p>Chimeric antigen receptor (CAR)-T is one of the most promising modern cancer immunotherapies. In the recent years, impressive results have been obtained in the treatment of cancer which led to FDA approval for the treatment of liquid tumors. In this cell-based therapy, immune cells (e.g. T and NK cells) are engineered to express a synthetic receptor CAR to specifically recognize and eliminate cells expressing a target antigen. CAR has evolved through different generations aiming to boost its biological activity and overcome limitations such as low persistence, limited potency, life-threatening toxicity and inefficient activity against solid tumor. The present review provides an overview of the different CAR generations, starting from the 1<sup>st</sup> generation with limited cytotoxic activity until the latest generation, the 5<sup>th</sup> generation or new generation, developed to overcome various limitations of CAR T therapy. The current ongoing clinical trials in cancer and autoimmune diseases, and the limitation associated with CAR-T cells in cancer therapy, are also discussed.</p>","PeriodicalId":18205,"journal":{"name":"M S-medecine Sciences","volume":"40 11","pages":"848-857"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Myonuclear domain settings by microtubules and MACF1]. [通过微管和 MACF1 设置肌核域]。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 Epub Date: 2024-11-18 DOI: 10.1051/medsci/2024134
Alireza Ghasemizadeh, Vincent Gache

Skeletal myofibers are syncytia made from the fusion of dozens or hundreds of mononuclear progenitor cells. Along myogenesis, the arriving nuclei from the progenitor cells have a long journey before being positioned at the periphery of a mature myofiber. Once at the periphery, nuclei are regularly spaced and each nucleus is transcriptionally responsible for its surrounding proportion of cytoplasm, known as the myonuclear domain. Disruption of these domains can be observed in various myopathies, suggesting their importance for skeletal muscle functionality. However, little is known about mechanisms regulating the myonuclear domain stability and organization. Here we take the example of MACF1, a microtubule-associated protein, as an essential actor in myonuclear domain organization, to highlight the potential role of microtubules and their associated proteome network for the stability of these domains and hence for proper myofiber functionality.

骨骼肌纤维是由数十或数百个单核祖细胞融合而成的合胞体。在肌形成过程中,祖细胞的细胞核经过漫长的旅程到达成熟肌纤维的外周。一旦到达外围,细胞核就会有规律地排列,每个细胞核都对其周围一定比例的细胞质(即肌核域)负有转录责任。在各种肌病中都能观察到这些结构域的破坏,这表明它们对骨骼肌功能的重要性。然而,人们对调节肌核结构域稳定性和组织性的机制知之甚少。在此,我们以微管相关蛋白 MACF1 为例,说明微管及其相关蛋白组网络对肌核结构域的稳定性以及肌纤维正常功能的潜在作用。
{"title":"[Myonuclear domain settings by microtubules and MACF1].","authors":"Alireza Ghasemizadeh, Vincent Gache","doi":"10.1051/medsci/2024134","DOIUrl":"10.1051/medsci/2024134","url":null,"abstract":"<p><p>Skeletal myofibers are syncytia made from the fusion of dozens or hundreds of mononuclear progenitor cells. Along myogenesis, the arriving nuclei from the progenitor cells have a long journey before being positioned at the periphery of a mature myofiber. Once at the periphery, nuclei are regularly spaced and each nucleus is transcriptionally responsible for its surrounding proportion of cytoplasm, known as the myonuclear domain. Disruption of these domains can be observed in various myopathies, suggesting their importance for skeletal muscle functionality. However, little is known about mechanisms regulating the myonuclear domain stability and organization. Here we take the example of MACF1, a microtubule-associated protein, as an essential actor in myonuclear domain organization, to highlight the potential role of microtubules and their associated proteome network for the stability of these domains and hence for proper myofiber functionality.</p>","PeriodicalId":18205,"journal":{"name":"M S-medecine Sciences","volume":"40 Hors série n° 1 ","pages":"64-68"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Urban soils and microbial biodiversity]. [城市土壤与微生物生物多样性]。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 Epub Date: 2024-12-10 DOI: 10.1051/medsci/2024147
Pierre-Alain Maron, Lionel Ranjard

Aware of the degradation of their environment, cities engage in a transition towards sustainable development models. They are based on the search for solutions promoting the "return of nature to the city", which is acclaimed by citizen wishing to improve their living environment. As a support of this nature, there is a knowledge issue regard soil to define management practices and design methods to optimize its functioning. Among this knowledge, that relating to the ecology and microbial diversity of the soil is essential since microorganisms are responsible for many of the services essential to the sustainability of urban systems. This article provides a brief overview of knowledge on the microbial diversity of urban soils and the tools available to assess it. It also presents examples of ongoing projects to study soil biodiversity in major French cities.

意识到环境的恶化,城市开始向可持续发展模式转型。这些模式以寻找促进 "自然回归城市 "的解决方案为基础,受到希望改善生活环境的市民的欢迎。作为对这种性质的支持,存在一个有关土壤的知识问题,以确定管理做法和设计方法,优化其功能。在这些知识中,与土壤生态学和微生物多样性有关的知识至关重要,因为微生物提供了许多对城市系统可持续性至关重要的服务。本文简要概述了有关城市土壤微生物多样性的知识和可用的评估工具。文章还介绍了法国主要城市正在进行的土壤生物多样性研究项目实例。
{"title":"[Urban soils and microbial biodiversity].","authors":"Pierre-Alain Maron, Lionel Ranjard","doi":"10.1051/medsci/2024147","DOIUrl":"https://doi.org/10.1051/medsci/2024147","url":null,"abstract":"<p><p>Aware of the degradation of their environment, cities engage in a transition towards sustainable development models. They are based on the search for solutions promoting the \"return of nature to the city\", which is acclaimed by citizen wishing to improve their living environment. As a support of this nature, there is a knowledge issue regard soil to define management practices and design methods to optimize its functioning. Among this knowledge, that relating to the ecology and microbial diversity of the soil is essential since microorganisms are responsible for many of the services essential to the sustainability of urban systems. This article provides a brief overview of knowledge on the microbial diversity of urban soils and the tools available to assess it. It also presents examples of ongoing projects to study soil biodiversity in major French cities.</p>","PeriodicalId":18205,"journal":{"name":"M S-medecine Sciences","volume":"40 11","pages":"858-863"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The pangenome integrates the vast genetic diversity of the human population]. [庞基因组整合了人类巨大的遗传多样性]。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 Epub Date: 2024-11-18 DOI: 10.1051/medsci/2024126
Louise Benarroch
{"title":"[The pangenome integrates the vast genetic diversity of the human population].","authors":"Louise Benarroch","doi":"10.1051/medsci/2024126","DOIUrl":"https://doi.org/10.1051/medsci/2024126","url":null,"abstract":"","PeriodicalId":18205,"journal":{"name":"M S-medecine Sciences","volume":"40 Hors série n° 1 ","pages":"75"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
M S-medecine Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1